Although the precise events that prime inflammation in spondyloarthritis is still unclear, recent findings provided evidence of the involvement of immune pathways, including the lately described IL-17/IL-23 pathway, NF-κB activation and antigen presentation [33] reintroducing the issue of autoimmune versus autoinflammatory disease. Here, NFKB1 is linked to spondyloarthropathy.